Article

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence

2026-05-12

Abstract excerpt

<h4>Purpose</h4> To develop and validate a multimodal recurrence-risk model integrating histology, genomic testing, and clinical variables. <h4>Methods</h4> We developed AI-Path, a whole-slide image biomarker for recurrence prediction trained in CALGB 9344, and validated it in three independent cohorts: TAILORx, a multi-site Chicago cohort, and the MDX-BRCA cohort. We then integrated AI-Path with Oncotype DX Rec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ef53972-ea26-589b-ba33-280e1e41c954
DOI: 10.64898/2026.05.08.26352562

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceDOI 10.64898/2026.05.08.26352562Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read

Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of RecurrenceSemantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerSemantic proximity Read

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitSemantic proximity Read

PreciseBreast is prognostic for breast cancer recurrence in a 21-gene assay managed cohortSemantic proximity Read

Assessing the risk of recurrence in early-stage breast cancer through H&E stained whole slide imagesSemantic proximity Read

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity Read

Prediction of OncotypeDX recurrence score using H&E stained WSI imagesSemantic proximity Read

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinomaSemantic proximity Read

Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised TransformerSemantic proximity Read

Evaluation of an AI-Based Digital Pathology Tool for Breast Cancer Recurrence RiskSemantic proximity Read